Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK706769 for maintenance of remission after Enbrel withdrawal in rheumatoid arthritis
2009-012204-42Phase 2Terminated
- Sponsor
- GSK
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing GSK706769 arm with Placebo arm (2 arms). Primary endpoint: Maintenance of remission at Day 28. Started Sep 2009; status: terminated.
02
Drugs
GSK706769
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-012204-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012204-42.